文献速递术前评估与围术期医学

四联比恢复至0.9-1.0后给予新斯的明:对神经肌肉与临床恢复影响的随机对照试验

Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery.
PubMed 文献 · Anesthesiology · 2018-01-01

这项双盲随机非劣效性试验在120例需插管手术患者中给予小剂量罗库溴铵,90例术毕四联比≥0.9者随机接受新斯的明40 μg/kg或生理盐水。两组四联比、术后低氧与气道梗阻事件相似,结论认为在神经肌肉恢复时给予新斯的明未出现抗胆碱酯酶所致肌无力的临床证据。

要点

  • 四联比≥0.9后给新斯的明40 μg/kg未增加肌无力临床证据。
  • 两组四联比在恢复前、恢复后5 min及PACU入室时无差异。
  • 术后低氧与气道梗阻事件发生率相似。

核心结论

  • 在神经肌肉恢复时给予新斯的明未出现抗胆碱酯酶诱导肌无力的临床证据。

研究设计与样本

  • 双盲、随机、非劣效性试验,共120例需插管手术患者接受小剂量罗库溴铵。
  • 90例术毕四联比≥0.9者随机接受新斯的明40 μg/kg或生理盐水。

主要发现

  • 对照组与新斯的明组恢复前四联比均值分别为1.02与1.03。
  • 恢复后5 min四联比均值分别为1.05与1.07。
  • PACU入室时四联比均值分别为1.06与1.08,均值差-0.018(95%CI -0.046至0.010)。
  • 术后低氧事件与气道梗阻发生率两组相似。
  • 术后肌无力症状体征患者数除复视外两组无差异,复视对照组13例、新斯的明组2例(P=0.001)。

临床怎么用

  • 对四联比已恢复至0.9或以上的患者,使用新斯的明40 μg/kg未观察到临床肌无力证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When a muscle relaxant is administered to facilitate intubation, the benefits of anticholinesterase reversal must be balanced with potential risks. The aim of this double-blinded, randomized noninferiority trial was to evaluate the effect of neostigmine administration on neuromuscular function when given to patients after spontaneous recovery to a train-of-four ratio of 0.9 or greater. METHODS: A total of 120 patients presenting for surgery requiring intubation were given a small dose of rocuronium. At the conclusion of surgery, 90 patients achieving a train-of-four ratio of 0.9 or greater were randomized to receive either neostigmine 40 μg/kg or saline (control). Train-of-four ratios were measured from the time of reversal until postanesthesia care unit admission. Patients were monitored for postextubation adverse respiratory events and assessed for muscle strength. RESULTS: Ninety patients achieved a train-of-four ratio of 0.9 or greater at the time of reversal. Mean train-of-four ratios in the control and neostigmine groups before reversal (1.02 vs. 1.03), 5 min postreversal (1.05 vs. 1.07), and at postanesthesia care unit admission (1.06 vs. 1.08) did not differ. The mean difference and corresponding 95% CI of the latter were -0.018 and -0.046 to 0.010. The incidences of postoperative hypoxemic events and episodes of airway obstruction were similar for the groups. The number of patients with postoperative signs and symptoms of muscle weakness did not differ between groups (except for double vision: 13 in the control group and 2 in the neostigmine group; P = 0.001). CONCLUSIONS: Administration of neostigmine at neuromuscular recovery was not associated with clinical evidence of anticholinesterase-induced muscle weakness. VISUAL ABSTRACT: An online visual overview is available for this article.(Figure is included in full-text article.).

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Murphy GS, Szokol JW, Avram MJ, et al. Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery. Anesthesiology. 2018. PMID: 28953501. doi:10.1097/ALN.0000000000001893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。